Cargando…

The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy

OBJECTIVE: The receptor activator of nuclear factor-κB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) signaling pathway (RANKL/RANK/OPG signaling) is implicated in the osteolysis associated with diabetic Charcot neuroarthropathy (CN); however, the links with medial arterial calcification (MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndip, Agbor, Williams, Alfred, Jude, Edward B., Serracino-Inglott, Ferdinand, Richardson, Steve, Smyth, J.V., Boulton, Andrew J.M., Alexander, M. Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142088/
https://www.ncbi.nlm.nih.gov/pubmed/21659498
http://dx.doi.org/10.2337/db10-1220
_version_ 1782208792382930944
author Ndip, Agbor
Williams, Alfred
Jude, Edward B.
Serracino-Inglott, Ferdinand
Richardson, Steve
Smyth, J.V.
Boulton, Andrew J.M.
Alexander, M. Yvonne
author_facet Ndip, Agbor
Williams, Alfred
Jude, Edward B.
Serracino-Inglott, Ferdinand
Richardson, Steve
Smyth, J.V.
Boulton, Andrew J.M.
Alexander, M. Yvonne
author_sort Ndip, Agbor
collection PubMed
description OBJECTIVE: The receptor activator of nuclear factor-κB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) signaling pathway (RANKL/RANK/OPG signaling) is implicated in the osteolysis associated with diabetic Charcot neuroarthropathy (CN); however, the links with medial arterial calcification (MAC) seen in people with CN are unclear. This study aimed to investigate the role of RANKL/OPG in MAC in patients with CN. RESEARCH DESIGN AND METHODS: Enzyme-linked immunosorbent assay and Bio-plex multiarray technology were used to quantify a range of cytokines, including RANKL and OPG in sera from 10 patients with diabetes, 12 patients with CN, and 5 healthy volunteers. Human tibial artery segments were immunohistochemically stained with Alizarin red and human RANKL antibody. Human vascular smooth muscle cells (VSMCs) were also explanted from arterial segments for in vitro studies. RESULTS: We demonstrate colocalization and upregulation of RANKL expression in areas displaying MAC. Systemic levels of RANKL, OPG, and inflammatory cytokines (interleukin-8, granulocyte colony–stimulating factor) were elevated in those with CN compared with diabetic patients and healthy control subjects. Human VSMCs cultured in CN serum showed accelerated osteoblastic differentiation (alkaline phosphatase activity) and mineralization (alizarin red staining) compared with cells treated with diabetic or control serum (P < 0.05). Coincubation with OPG, the decoy receptor for RANKL, attenuated osteogenic differentiation of VSMCs and was independent of a high calcium-phosphate milieu. The accelerated mineralization induced by RANKL and CN serum correlated with nuclear translocation of nuclear factor-κB, a process abrogated by OPG. CONCLUSIONS: Our data provide direct evidence that RANKL/RANK/OPG signaling is modulated in patients with CN and plays a role in vascular calcification. This study highlights this pathway as a potential target for intervention.
format Online
Article
Text
id pubmed-3142088
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31420882012-08-01 The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy Ndip, Agbor Williams, Alfred Jude, Edward B. Serracino-Inglott, Ferdinand Richardson, Steve Smyth, J.V. Boulton, Andrew J.M. Alexander, M. Yvonne Diabetes Complications OBJECTIVE: The receptor activator of nuclear factor-κB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) signaling pathway (RANKL/RANK/OPG signaling) is implicated in the osteolysis associated with diabetic Charcot neuroarthropathy (CN); however, the links with medial arterial calcification (MAC) seen in people with CN are unclear. This study aimed to investigate the role of RANKL/OPG in MAC in patients with CN. RESEARCH DESIGN AND METHODS: Enzyme-linked immunosorbent assay and Bio-plex multiarray technology were used to quantify a range of cytokines, including RANKL and OPG in sera from 10 patients with diabetes, 12 patients with CN, and 5 healthy volunteers. Human tibial artery segments were immunohistochemically stained with Alizarin red and human RANKL antibody. Human vascular smooth muscle cells (VSMCs) were also explanted from arterial segments for in vitro studies. RESULTS: We demonstrate colocalization and upregulation of RANKL expression in areas displaying MAC. Systemic levels of RANKL, OPG, and inflammatory cytokines (interleukin-8, granulocyte colony–stimulating factor) were elevated in those with CN compared with diabetic patients and healthy control subjects. Human VSMCs cultured in CN serum showed accelerated osteoblastic differentiation (alkaline phosphatase activity) and mineralization (alizarin red staining) compared with cells treated with diabetic or control serum (P < 0.05). Coincubation with OPG, the decoy receptor for RANKL, attenuated osteogenic differentiation of VSMCs and was independent of a high calcium-phosphate milieu. The accelerated mineralization induced by RANKL and CN serum correlated with nuclear translocation of nuclear factor-κB, a process abrogated by OPG. CONCLUSIONS: Our data provide direct evidence that RANKL/RANK/OPG signaling is modulated in patients with CN and plays a role in vascular calcification. This study highlights this pathway as a potential target for intervention. American Diabetes Association 2011-08 2011-07-18 /pmc/articles/PMC3142088/ /pubmed/21659498 http://dx.doi.org/10.2337/db10-1220 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Complications
Ndip, Agbor
Williams, Alfred
Jude, Edward B.
Serracino-Inglott, Ferdinand
Richardson, Steve
Smyth, J.V.
Boulton, Andrew J.M.
Alexander, M. Yvonne
The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy
title The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy
title_full The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy
title_fullStr The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy
title_full_unstemmed The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy
title_short The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy
title_sort rankl/rank/opg signaling pathway mediates medial arterial calcification in diabetic charcot neuroarthropathy
topic Complications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142088/
https://www.ncbi.nlm.nih.gov/pubmed/21659498
http://dx.doi.org/10.2337/db10-1220
work_keys_str_mv AT ndipagbor theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT williamsalfred theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT judeedwardb theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT serracinoinglottferdinand theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT richardsonsteve theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT smythjv theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT boultonandrewjm theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT alexandermyvonne theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT ndipagbor ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT williamsalfred ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT judeedwardb ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT serracinoinglottferdinand ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT richardsonsteve ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT smythjv ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT boultonandrewjm ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy
AT alexandermyvonne ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy